Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jhonny Azuaje

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Medicinal Chemistry|December 14, 2022
Exploring the Effect of Halogenation in a Series of Potent and Selective A<sub>2B</sub> Adenosine Receptor AntagonistsRubén Prieto-Díaz, Manuel González-Gómez, Hugo Fojo-Carballo, et al.
Journal of Medicinal Chemistry|December 29, 2020
3,4-Dihydropyrimidin-2(1<i>H</i>)-ones as Antagonists of the Human A<sub>2B</sub> Adenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific RecognitionMaría Majellaro, Willem Jespers, Abel Crespo, et al.
Journal of Medicinal Chemistry|August 12, 2025
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB<sub>2</sub> Agonists with Neuroprotective EffectsClaudia Gioé-Gallo, Sandra Ortigueira, Rubén Prieto-Díaz, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Medicinal Chemistry|December 14, 2022
Exploring the Effect of Halogenation in a Series of Potent and Selective A<sub>2B</sub> Adenosine Receptor AntagonistsRubén Prieto-Díaz, Manuel González-Gómez, Hugo Fojo-Carballo, et al.
Journal of Medicinal Chemistry|December 29, 2020
3,4-Dihydropyrimidin-2(1<i>H</i>)-ones as Antagonists of the Human A<sub>2B</sub> Adenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific RecognitionMaría Majellaro, Willem Jespers, Abel Crespo, et al.
Journal of Medicinal Chemistry|August 12, 2025
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB<sub>2</sub> Agonists with Neuroprotective EffectsClaudia Gioé-Gallo, Sandra Ortigueira, Rubén Prieto-Díaz, et al.
Pageof 4